Literature DB >> 19304699

Value of dynamic contrast-enhanced MRI and correlation with tumor angiogenesis in bladder cancer.

Nermin Tuncbilek1, Mustafa Kaplan, Semsi Altaner, Irfan H Atakan, Necdet Süt, Osman Inci, Mustafa Kemal Demir.   

Abstract

OBJECTIVE: The aim of this study was to investigate dynamic contrast-enhanced MRI (DCE-MRI) for the noninvasive measurement of bladder cancer angiogenesis by correlation with microvessel density, histologic grade, and tumor staging, and to predict the outcome of local recurrence.
MATERIALS AND METHODS: Twenty-four patients with bladder cancer were examined using DCE-MRI. Hemodynamic parameters obtained by DCE-MRI included peak time enhancement in the first minute (E(max/1)) after contrast administration, second minute (E(max/2)), third minute (E(max/3)), fourth minute (E(max/4)), and fifth minute (E(max/5)), and the steepest slope. Microvessel density was identified by immunostaining of endothelial cells using FVIII-related antigen. The Mann-Whitney U test, multivariate discriminant analysis, Spearman's correlation coefficient, and analysis of variance were used for statistical analysis.
RESULTS: Correlation was seen between DCE-MRI parameters (E(max/1) and steepest slope) and microvessel density (p < 0.05). E(max/1) and steepest slope were found to have a statistically significant correlation with histologic grade (p < 0.05 and p < 0.01, respectively). A significant difference was seen between groups of patients with and without local recurrence with regard to two of the DCE-MRI parameters (p < 0.05 for E(max/1) and E(max/2)).
CONCLUSION: The contrast enhancement patterns on DCE-MRI are influenced by tumor angiogenesis, as reflected by elevated microvessel density expression. Therefore, they are valuable indicators for assessing tumor angiogenic activity and tumor neovascularization in bladder cancers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19304699     DOI: 10.2214/AJR.08.1332

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  24 in total

1.  Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?

Authors:  Christopher Klenk; Rakhee Gawande; Vy Thao Tran; Jennifer Trinh Leung; Kevin Chi; Daniel Owen; Sandra Luna-Fineman; Kathleen M Sakamoto; Alex McMillan; Andy Quon; Heike E Daldrup-Link
Journal:  J Nucl Med       Date:  2015-10-15       Impact factor: 10.057

Review 2.  Preoperative imaging for staging bladder cancer.

Authors:  Maxim J McKibben; Michael E Woods
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

Review 3.  Imaging angiogenesis of genitourinary tumors.

Authors:  Ying-Kiat Zee; James P B O'Connor; Geoff J M Parker; Alan Jackson; Andrew R Clamp; M Ben Taylor; Noel W Clarke; Gordon C Jayson
Journal:  Nat Rev Urol       Date:  2010-01-19       Impact factor: 14.432

4.  Ultrafast Dynamic Contrast-Enhanced Breast MRI: Kinetic Curve Assessment Using Empirical Mathematical Model Validated with Histological Microvessel Density.

Authors:  Naoko Mori; Hiroyuki Abe; Shunji Mugikura; Chiaki Takasawa; Satoko Sato; Minoru Miyashita; Yu Mori; Federico D Pineda; Gregory S Karczmar; Hajime Tamura; Shoki Takahashi; Kei Takase
Journal:  Acad Radiol       Date:  2018-09-28       Impact factor: 3.173

5.  PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging.

Authors:  Svetlana Balyasnikova; Johan Löfgren; Robin de Nijs; Yanna Zamogilnaya; Liselotte Højgaard; Barbara M Fischer
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-10-15

6.  Comparison of Coregistration Accuracy of Pelvic Structures Between Sequential and Simultaneous Imaging During Hybrid PET/MRI in Patients with Bladder Cancer.

Authors:  Andrew B Rosenkrantz; Arjun V Balar; William C Huang; Kimberly Jackson; Kent P Friedman
Journal:  Clin Nucl Med       Date:  2015-08       Impact factor: 7.794

Review 7.  Role of Multiparametric MR Imaging in Malignancies of the Urogenital Tract.

Authors:  Alberto Diaz de Leon; Daniel Costa; Ivan Pedrosa
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

8.  PET/CT and MRI in Bladder Cancer.

Authors:  Kirsten Bouchelouche; Baris Turkbey; Peter L Choyke
Journal:  J Cancer Sci Ther       Date:  2012-07-30

9.  Performance of simultaneous high temporal resolution quantitative perfusion imaging of bladder tumors and conventional multi-phase urography using a novel free-breathing continuously acquired radial compressed-sensing MRI sequence.

Authors:  Nainesh Parikh; Justin M Ream; Hoi Cheung Zhang; Kai Tobias Block; Hersh Chandarana; Andrew B Rosenkrantz
Journal:  Magn Reson Imaging       Date:  2015-12-29       Impact factor: 2.546

10.  Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage.

Authors:  Bingsheng Huang; Chun-Sing Wong; Brandon Whitcher; Dora Lai-Wan Kwong; Vincent Lai; Queenie Chan; Pek-Lan Khong
Journal:  Eur Radiol       Date:  2013-02-02       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.